Let’s start up with the current stock price of Intercept Pharmaceuticals Inc. (ICPT), which is $29.54 to be very precise. The Stock rose vividly during the last session to $31.70 after opening rate of $31.60 while the lowest price it went was recorded $28.62 before closing at $31.26.
Recently in News on January 11, 2021, Intercept Appoints Jared M. Freedberg as General Counsel and Secretary. Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, today announced the appointment of Jared M. Freedberg as General Counsel and Secretary. Mr. Freedberg joins Intercept from Immunomedics, Inc., which was acquired by Gilead Sciences in October of 2020. You can read further details here
Gold bugs are shouting from the rooftops in excitement, but that doesn’t mean you rush out and just buy any gold stock…That’s why we laid out The 2021 Ultimate Gold Portfolio – to dissect the treasure from the trash.
Intercept Pharmaceuticals Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $31.74 on 01/07/21, with the lowest value was $23.78 for the same time period, recorded on 01/04/21.
Intercept Pharmaceuticals Inc. (ICPT) full year performance was -72.74%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Intercept Pharmaceuticals Inc. shares are logging -74.31% during the 52-week period from high price, and 24.20% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $23.78 and $114.99.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 1785660 for the day, which was evidently higher, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Intercept Pharmaceuticals Inc. (ICPT) recorded performance in the market was 19.60%, having the revenues showcasing -12.29% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 976.89M, as it employees total of 583 workers.
Intercept Pharmaceuticals Inc. (ICPT) in the eye of market guru’s
During the last month, 7 analysts gave the Intercept Pharmaceuticals Inc. a BUY rating, 2 of the polled analysts branded the stock as an OVERWEIGHT, 15 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 36.19, with a change in the price was noted -18.96. In a similar fashion, Intercept Pharmaceuticals Inc. posted a movement of -39.09% for the period of last 100 days, recording 871,773 in trading volumes.
Intercept Pharmaceuticals Inc. (ICPT): Stocks Technical analysis and Trends
Raw Stochastic average of Intercept Pharmaceuticals Inc. in the period of last 50 days is set at 34.62%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 55.58%. In the last 20 days, the company’s Stochastic %K was 62.99% and its Stochastic %D was recorded 62.21%.
If we look into the earlier routines of Intercept Pharmaceuticals Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 19.60%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -32.01%, alongside a downfall of -72.74% for the period of the last 12 months. The shares increased approximately by -5.17% in the 7-day charts and went up by -10.32% in the period of the last 30 days. Common stock shares were lifted by -12.29% during last recorded quarter.